Impact of variation in patient response on model-based control of glycaemia in critically ill patients
暂无分享,去创建一个
J. Geoffrey Chase | Geoffrey M. Shaw | Christopher G. Pretty | Aaron J. Le Compte | Adrienne Lynn | Jessica Lin | J. Chase | A. Lynn | G. Shaw | C. Pretty | A. Compte | Jessica Lin | A. L. Le Compte | J. Chase
[1] M. Walsh,et al. Total parenteral nutrition-associated hyperglycemia correlates with prolonged mechanical ventilation and hospital stay in septic infants. , 2006, Journal of pediatric surgery.
[2] Christopher E. Hann,et al. Integral-based parameter identification for long-term dynamic verification of a glucose-insulin system model , 2005, Comput. Methods Programs Biomed..
[3] M Schetz,et al. Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.
[4] J Lewejohann,et al. The course of the oxygenation index before kinetic therapy or prone ventilation is decisive for the prognosis of acute respiratory failure , 2006, Critical Care.
[5] Richard Hellman,et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. , 2009, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[6] W. Oh,et al. Persistent glucose production during glucose infusion in the neonate. , 1983, The Journal of clinical investigation.
[7] M Olovsson,et al. The brain is a major source of S100 increase in porcine endotoxemic shock , 2009, Critical Care.
[8] Marcus J. Schultz,et al. The Society of Critical Care Medicine , 1989 .
[9] Christopher E. Hann,et al. Model-based glycaemic control in critical care - A review of the state of the possible , 2006, Biomed. Signal Process. Control..
[10] J. Geoffrey Chase,et al. Blood Glucose Controller for Neonatal Intensive Care: Virtual Trials Development and First Clinical Trials , 2009, Journal of diabetes science and technology.
[11] B. Bistrian,et al. Intensive insulin therapy in critically ill patients. , 2002, The New England journal of medicine.
[12] Rinaldo Bellomo,et al. Variability of Blood Glucose Concentration and Short-term Mortality in Critically Ill Patients , 2006, Anesthesiology.
[13] Deborah J. Cook,et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data , 2009, Canadian Medical Association Journal.
[14] Christopher E. Hann,et al. Stochastic modelling of insulin sensitivity and adaptive glycemic control for critical care , 2008, Comput. Methods Programs Biomed..
[15] A. Malhotra,et al. Stress-induced hyperglycemia. , 2001, Critical care clinics.
[16] A. Sunehag,et al. Hyperglycemia Is a Risk Factor for Early Death and Morbidity in Extremely Low Birth-Weight Infants , 2006, Pediatrics.
[17] S Andreassen,et al. Model predictive glycaemic regulation in critical illness using insulin and nutrition input: a pilot study. , 2006, Medical engineering & physics.
[18] E Futier,et al. ScvO2 and Pcv-aCO2 as complementary tools for goal-directed therapy during high-risk surgery , 2010, Critical Care.
[19] Jaap E Tulleken,et al. Towards a feasible algorithm for tight glycaemic control in critically ill patients: a systematic review of the literature , 2006, Critical care.
[20] Christopher E. Hann,et al. Development of blood glucose control for extremely premature infants , 2011, Comput. Methods Programs Biomed..
[21] T. Ertl,et al. Relationship between Hyperglycemia and Retinopathy of Prematurity in Very Low Birth Weight Infants , 2006, Neonatology.
[22] Mike Thompson,et al. A randomised controlled trial of early insulin therapy in very low birth weight infants, "NIRTURE" (neonatal insulin replacement therapy in Europe) , 2007, BMC pediatrics.
[23] B. Bistrian,et al. Hyperglycemia and infection: which is the chicken and which is the egg? , 2001, JPEN. Journal of parenteral and enteral nutrition.
[24] Christopher E. Hann,et al. A physiological Intensive Control Insulin-Nutrition-Glucose (ICING) model validated in critically ill patients , 2011, Comput. Methods Programs Biomed..
[25] Rinaldo Bellomo,et al. The impact of early hypoglycemia and blood glucose variability on outcome in critical illness , 2009, Critical care.
[26] Christopher E. Hann,et al. Overview of Glycemic Control in Critical Care: Relating Performance and Clinical Results , 2007, Journal of diabetes science and technology.
[27] Bart Meyns,et al. Tight glycemic control protects the myocardium and reduces inflammation in neonatal heart surgery. , 2010, The Annals of thoracic surgery.
[28] Jean-Charles Preiser,et al. Clinical experience with tight glucose control by intensive insulin therapy , 2007, Critical care medicine.
[29] Dominic S. Lee,et al. Implementation and evaluation of the SPRINT protocol for tight glycaemic control in critically ill patients: a clinical practice change , 2008, Critical care.
[30] H. Gerstein,et al. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview , 2000, The Lancet.
[31] Thomas Desaive,et al. Organ failure and tight glycemic control in the SPRINT study , 2010, Critical care.
[32] W. Oh,et al. Persistent glucose production and greater peripheral sensitivity to insulin in the neonate vs. the adult. , 1997, The American journal of physiology.
[33] Thomas Lotz,et al. A simple insulin-nutrition protocol for tight glycemic control in critical illness: development and protocol comparison. , 2006, Diabetes technology & therapeutics.
[34] Sergio Kiffer Macedo,et al. A comparative study between conventional and antimicrobial-filled central venous catheters , 2008, Critical Care.
[35] G. Van den Berghe,et al. Metabolic, endocrine, and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness. , 2003, Endocrinology.
[36] Thomas Desaive,et al. Validation of a model-based virtual trials method for tight glycemic control in intensive care , 2010, Biomedical engineering online.
[37] J. Magny,et al. Both relative insulin resistance and defective islet beta-cell processing of proinsulin are responsible for transient hyperglycemia in extremely preterm infants. , 2004, Pediatrics.
[38] Joan Renaud Smith,et al. Insulin Infusion for the Treatment of Hyperglycemia in Low Birth Weight Infants: Examining the Evidence , 2008, Neonatal Network.